NL-OMON48324
Completed
Not Applicable
A multicentre study to use non-invasive methods including hyperSPECTral imaging, thermal imaging and tcPO2 for monitoring tissue perfusion in vAsCULAR patients in-hospital and at home -- The SPECTACULAR-study - The SPECTACULAR-study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Peripheral arterial disease - Constricted bloodflow to the legs
- Sponsor
- niversitair Medisch Centrum Groningen
- Enrollment
- 432
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who are 18 years and older with peripheral arterial disease; non\- critical limb ischemia (Rutherford classification 2 and 3\) or critical limb ischemia (Rutherford classification 4 to 6\). Written informed consent
Exclusion Criteria
- •Patients with insufficient knowledge of the Dutch language, illiteracy or language barrier
- •Patients with severe peripheral oedema.
- •Patient with severe cardiac\-pulmonary failure
- •Patients with active cellulitis\-erysipelas of the legs or other dermatological diseases of the legs.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
The SPECTACULAR-studyPeripheral arterial disease, PAD, Hyperspectral imaging, thermal imaging, tissue perfusion, tissue ischemia, wound healingNL-OMON28679niversity Medical Centre Groningen Hanzeplein 1, 9713 GZ GroningenThe Netherlands652
Completed
Not Applicable
A Non-interventional, multicentre study to see prevalence of BRCA1 and BRCA2 mutation among ovarian, primary peritoneal and fallopian tube cancer patients in IndiaCTRI/2018/08/015338AstraZeneca Pharma India Ltd
Completed
Not Applicable
on-interventional study to compare metabolic parameters(including lipid tests, insulin sensitivity, liver fat, visceral/ subcutaneous fat)between diabetic and healthy subjectsHealth Condition 1: null- Diabetic patientsCTRI/2011/07/001904Torrent Pharmaceuticals Limited150
Completed
Not Applicable
multicenter non-randomized non-blind exploratory clinical trial of safety and efficacy of cidofovir for adenovirus infection after hematopoietic stem cell transplantatioJPRN-UMIN000011158orth Japan Hematology Study Group10
Active, not recruiting
Phase 1
A multi-stage clinical study to develop a non-invasive Short Synacthen Test (SST) with nasally administered synacthen and salivary cortisol. The validated non-invasive SST will be used to establish normative data in children and to detect adrenal suppression in asthmatic children. - The development of a non-invasive Short Synacthen Test - NeSST StudyIn stages 1+2 of the study healthy volunteers will be used to determine the bioequivalence of nasal synacthen with 1 microgram of intravenous synacthen. Stage 3 will use healthy children to establish normal ranges for the adrenal response to a low-dose synacthen test. In stage 4 adrenal function in asthmatic individuals on inhaled corticosteroids will be studied.MedDRA version: 9.0Level: PTClassification code 10001367Term: Adrenal InsufficiencyMedDRA version: 9.0Level: PTClassification code 10006482Term: BronchospasmEUCTR2009-013355-29-GBSheffield Children's NHS Foundation Hospital258